BDRX Biodexa Pharmaceuticals
- 0.9644
- +0.0045+0.47%
- 0.9799
- +0.0155+1.61%
Biodexa Pharmaceuticals News
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | F-1: Registration statement for securities of certain foreign private issuers
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Biodexa Pharmaceuticals | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Biodexa Pharmaceuticals | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Biodexa Pharmaceuticals | F-1: Registration statement for securities of certain foreign private issuers
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
